Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 872, Issue 1-2, 2008, Pages 77-82

  Sparidans, Rolf W ^a   Lagas, Jurjen S ^b   Schinkel, Afred H ^b   Schellens, Jan H M ^a,b   Beijnen, Jos H ^a,b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

4 Hydroxy diclofenac; 5 Hydroxy diclofenac; Diclofenac; Diclofenac acyl glucuronide; LC MS MS; Mouse plasma

Indexed keywords

ACETIC ACID; BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; KETONES; MASS SPECTROMETERS; ORGANIC ACIDS; PLASMAS; POSITIVE IONS; SPECTROMETRY; STANDARDS;

5-HYDROXY-DICLOFENAC; ANALYTES; ASCORBIC ACID; DICLOFENAC; DICLOFENAC-ACYL-GLUCURONIDE; GLUCURONIDE; INTERNAL STANDARD; LC/MS/MS; MOUSE PLASMA; SAMPLE PRE-TREATMENT; SIMULTANEOUS DETERMINATIONS; TANDEM MASS SPECTROMETRIC;

LIQUID CHROMATOGRAPHY;

4' HYDROXY DICLOFENAC; 5 HYDROXY DICLOFENAC; ACETIC ACID; ACETONITRILE; AMMONIUM ACETATE; ASCORBIC ACID; DICLOFENAC; DICLOFENAC ACYL GLUCORONIDE; DRUG METABOLITE; FORMIC ACID; METHANOL; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG STABILITY; ELECTROSPRAY; ELUTION; IONIZATION; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; STANDARD; SUPERNATANT; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALIBRATION; DICLOFENAC; HALF-LIFE; MALE; MICE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

MUS;

EID: 50049083535     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.07.012     Document Type: Article

References (25)

1. Peris-Ribera J.E., Torres-Molina F., Garcia-Carbonell M.C., Aristorena J.C., and Pla-Delfina J.M. J. Pharmacokinet. Biopharm. 19 (1991) 647
2. Davies N.M., and Anderson K.E. Clin. Pharmacokinet. 33 (1997) 184
3. Willis J.V., Kendall M.J., Flinn R.M., Thornhill D.P., and Welling P.G. Eur. J. Clin. Pharmacol. 16 (1979) 405
4. Willis J.V., Kendall M.J., and Jack D.B. Eur. J. Clin. Pharmacol. 18 (1980) 415
5. Tsuchiya T., Terakawa M., Ishibashi K., Noguchi H., and Kato R. Arzneimittelforschung 30 (1980) 1650
6. Seitz S., Kretz-Rommel A., Oude Elferink R.P., and Boelsterli U.A. Chem. Res. Toxicol. 11 (1998) 513
7. Vlaming M.L., Mohrmann K., Wagenaar E., de Waart D.R., Elferink R.P., Lagas J.S., van Tellingen O., Vainchtein L.D., Rosing H., Beijnen J.H., Schellens J.H., and Schinkel A.H. J. Pharmacol. Exp. Ther. 318 (2006) 319
8. Lagas J.S., Vlaming M.L., van Tellingen O., Wagenaar E., Jansen R.S., Rosing H., Beijnen J.H., and Schinkel A.H. Clin. Cancer Res. 12 (2006) 6125
9. Hinz B., Auge D., Rau T., Rietbrock S., Brune K., and Werner U. Biomed. Chromatogr. 17 (2003) 268
10. Schneider W., and Degen P.H. J. Chromatogr. 383 (1986) 412
11. Zecca L., Ferrario P., and Costi P. J. Chromatogr. 567 (1991) 425
12. Schneider W., and Degen P.H. J. Chromatogr. 217 (1981) 263
13. Schweizer A., Willis J.V., Jack D.B., and Kendall M.J. J. Chromatogr. 195 (1980) 421
14. Godbillon J., Gauron S., and Metayer J.P. J. Chromatogr. 338 (1985) 151
15. Dorado P., Berecz R., Caceres M.C., and Llerena A. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 789 (2003) 437
16. Sawchuk R.J., Maloney J.A., Cartier L.L., Rackley R.J., Chan K.K., and Lau H.S. Pharm. Res. 12 (1995) 756
17. Kaphalia L., Kaphalia B.S., Kumar S., Kanz M.F., and Treinen-Moslen M. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 830 (2006) 231
18. Kumar S., Samuel K., Subramanian R., Braun M.P., Stearns R.A., Chiu S.H., Evans D.C., and Baillie T.A. J Pharmacol. Exp. Ther. 303 (2002) 969
19. King C., Tang W., Ngui J., Tephly T., and Braun M. Toxicol. Sci. 61 (2001) 49
20. Center for Drug Evaluation and Research of the U.S. Department of Health and Human Services Food and Drug Administration, Guidance for industry; Bioanalytical method validation, 2001, http://www.fda.gov/cder/guidance/4252fnl.htm, Accessed: June 19, 2006.
21. Rosing H., Man W.Y., Doyle E., Bult A., and Beijnen J.H. J. Liq. Chromatogr. Rel. Technol. 23 (2000) 329
22. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551
23. Schmitz G., Lepper H., and Estler C.J. J. Chromatogr. 620 (1993) 158
24. Walker G.S., Atherton J., Bauman J., Kohl C., Lam W., Reily M., Lou Z., and Mutlib A. Chem. Res. Toxicol. 20 (2007) 876
25. Shen S., Marchick M.R., Davis M.R., Doss G.A., and Pohl L.R. Chem. Res. Toxicol. 12 (1999) 214